Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Ordinary Shares, par value GBP 0.003 per share
-
Shares outstanding
-
792,553,191
-
Total 13F shares
-
78,538,884
-
Share change
-
+8,589,348
-
Total reported value
-
$181,392,642
-
Put/Call ratio
-
12%
-
Price per share
-
$2.31
-
Number of holders
-
60
-
Value change
-
+$20,402,688
-
Number of buys
-
33
-
Number of sells
-
20
Institutional Holders of Mereo BioPharma Group plc - Ordinary Shares, par value GBP 0.003 per share (MREO) as of Q4 2023
As of 31 Dec 2023,
Mereo BioPharma Group plc - Ordinary Shares, par value GBP 0.003 per share (MREO) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
78,538,884 shares.
The largest 10 holders included
Rubric Capital Management LP, Soleus Capital Management, L.P., MANGROVE PARTNERS, Rock Springs Capital Management LP, SUVRETTA CAPITAL MANAGEMENT, LLC, 683 Capital Management, LLC, ALKEON CAPITAL MANAGEMENT LLC, Tejara Capital Ltd, Clearline Capital LP, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
60
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.